Breast Cancer

After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.

When my daughter was diagnosed with breast cancer, writing our truth helped me and others face the harsh realities and lasting impact of cancer survivorship.

Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.

July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.

Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.

When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.

Hiking helped to sustain me through cancer treatment, with its emphasis on fresh air, natural wonders, and the companionship of friends.

Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.

After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.

A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.

I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.

Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.

After eleven 11 of survivorship, I’ve been waiting to hear the words, “You’re completely free of cancer! Go in peace,” but I’m wondering if it ever will happen.

My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.

In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.

Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after breast cancer treatment.

It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me accept my new normal.

At 12 years of age, I felt embarrassed by my mother’s cancer, but at 47, I see her as the strongest, most beautiful warrior I’ve ever known.

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.

If I’d gone flat after my mastectomy, I might be healthy now, but my breast implants led to more cancer, heart failure and years of pain.

Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.

After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the body I once had.

After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.

Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.

The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.